Los puntos clave no están disponibles para este artículo en este momento.
In the face of an epidemic of misuse of prescription opioids and related deaths, many states have created prescription-drug monitoring programs to track prescribing of controlled substances. As such programs are developed, expanded, or retooled, reanalysis is in order.
Perrone et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: